P38MAPK was activated using anisomycin, and we measured the GM1/GD1a ganglioside ratio. Anisomycin treatment led to a 100% ... Anisomycin treatment led to a mild increase in pP38MAPK/P38MAPK, and this in turn resulted in a 3.5-fold increase in the ratio ... P38MAPK in uncut axons in the absence of eCa2+ was first activated by a common P38MAPK activator, anisomycin (Katoh-Semba et al ... Although anisomycin is not entirely specific to p38, coupled with the other results, the experiment suggests that Neu3 ...

Anisomycin had no effect on the baseline EPSP (95 ± 12% at 3 hr; n = 2). Although anisomycin could have additional molecular ... whereas the baseline EPSP was not affected by anisomycin. Anisomycin was applied from 30 min before until 25 min after the ... 1988) Anisomycin, an inhibitor of protein synthesis, blocks late phase of LTP phenomena in the hippocampal CA1 region in vitro. ... anisomycin, actinomycin D, Nω-nitro-l-arginine, and picrotoxin from Sigma (St. Louis, MO); 1H-[1,2,4]oxadiazolo[4,3-α] ...

Profound Suppression of Neural Activity following Intracerebral Administration of the Protein Synthesis Inhibitor Anisomycin ...

2006) Anisomycin infused into the hippocampus fails to block "reconsolidation" but impairs extinction: the role of re-exposure ...

... cones displayed incorporation of 3H-leucine that was inhibited by treatment with the protein synthesis inhibitors anisomycin ...